prof. dr. Els Goetghebeur
- ORCID iD
-
0000-0002-8896-0721
Show
Sort by
-
- Journal Article
- A1
- open access
Health-related quality of life outcomes of salvage metastasis-directed treatment versus elective nodal treatment for oligorecurrent nodal prostate cancer : a secondary analysis of the phase 2, open-label PEACE V–STORM randomized trial
-
Propensity weighting plus adjustment in proportional hazards model is not doubly robust," by Erin E. Gabriel, Michael C. Sachs, Ingeborg Waernbaum, Els Goetghebeur, Paul F. Blanche, Stijn Vansteelandt, Arvid Sjölander, and Thomas Scheike( vol 80 ,10.1093/biomtc/ujae069 , 2024)
-
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials
-
Incidence and determinants of graft failure and death with functioning graft after re-transplantation
-
- Miscellaneous
- open access
Commentary : regression models-efforts are required to improve statistical practice and teaching
-
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial
-
Handling missing values in patient-reported outcome data in the presence of intercurrent events
-
- Journal Article
- A1
- open access
Factors associated with statural growth in pediatric kidney transplant recipients with focus on metabolic acidosis
-
- Journal Article
- A1
- open access
Propensity weighting plus adjustment in proportional hazards model is not doubly robust
-
- Miscellaneous
- open access
Budget impact projections for pharmaceuticals